Spots Global Cancer Trial Database for metastatic chordoma
Every month we try and update this database with for metastatic chordoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | NCT03623854 | Chordoma Locally Advance... Metastatic Chor... Unresectable Ch... | Nivolumab Relatlimab | 12 Years - | Jonsson Comprehensive Cancer Center | |
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma | NCT05041127 | Chordoma Metastatic Chor... Unresectable Ch... | Cetuximab Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | NCT03623854 | Chordoma Locally Advance... Metastatic Chor... Unresectable Ch... | Nivolumab Relatlimab | 12 Years - | Jonsson Comprehensive Cancer Center |